SCHEMBL2495396

SCHEMBL2495396

COc1c(C)cccc1C1(O)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBX7 O95931 2/20 0.48
CDYL Q9Y232 2/20 0.48
KMT2A Q03164 4/20 0.47
IDO1 P14902 2/20 0.45
BRD4 O60885 4/20 0.43
POLB P06746 1/20 0.43
CASP6 P55212 1/20 0.43
MEN1 O00255 2/20 0.40
LRRK2 Q5S007 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
ALOX12 P18054 1/20 0.40
PGR P06401 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.39
CDYL2 Q8N8U2 1/20 0.39
CDY1; CDY1B Q9Y6F8 1/20 0.39
ADCY8 P40145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4590131 0.88 KMT2A (0.56) CBX7CDYLKMT2AIDO1BRD4
SCHEMBL2497474 0.84 BRD4 (0.57) CBX7CDYLKMT2AIDO1BRD4
SCHEMBL4590153 0.83 KMT2A (0.50) CBX7CDYLKMT2AIDO1BRD4
SCHEMBL1464565 0.81 KMT2A (0.72) CBX7CDYLKMT2AIDO1POLB
SCHEMBL2493174 0.80 KMT2A (0.55) CBX7CDYLKMT2AIDO1BRD4
SCHEMBL2495393 0.79 KMT2A (0.57) CBX7CDYLKMT2AIDO1BRD4
SCHEMBL1464958 0.77 KMT2A (0.46) CBX7CDYLKMT2AIDO1BRD4
SCHEMBL6794872 0.77 IDO1 (0.47) CBX7CDYLKMT2AIDO1BRD4
SCHEMBL2497604 0.77 KMT2A (0.51) CBX7CDYLKMT2AIDO1BRD4
SCHEMBL2496356 0.77 KMT2A (0.51) CBX7CDYLKMT2AIDO1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 CBX7 4226/4885CDYL 3793/4885KMT2A 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.